TRK inhibitors

Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Tue, 09/24/19 - 09:28 am
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer